Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Prime Medicine, Inc. (PRME) had Return on Equity of -86.41% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.11M |
|
$-52.59M |
|
-- |
|
$1.11M |
|
$54.49M |
|
$-53.38M |
|
$0.79M |
|
$-52.59M |
|
$-53.12M |
|
$-52.59M |
|
$-52.59M |
|
$-52.59M |
|
$-53.12M |
|
$-53.38M |
|
$-51.92M |
|
129.19M |
|
129.19M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$121.29M |
|
$23.83M |
|
$157.72M |
|
$279.01M |
|
$34.11M |
|
-- |
|
$184.04M |
|
$218.15M |
|
$60.86M |
|
$60.86M |
|
$60.86M |
|
134.49M |
|
| Cash Flow Statement Financials | |
$-90.27M |
|
$-44.97M |
|
$6.20M |
|
$196.54M |
|
$67.50M |
|
$-129.04M |
|
$12.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4787.18% |
|
-4787.18% |
|
-- |
|
-4716.68% |
|
-4716.68% |
|
$-94.26M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
9.29 |
|
9.69 |
|
|
Return on Equity |
-86.41% |
-86.41% |
|
-18.85% |
|
-86.41% |
|
$0.45 |
|
$-0.73 |
|
$-0.70 |
|